Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 20.17
(-0.93%)
CNY 20.17
(-0.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -226.91 Million CNY | 50.81% |
| 2022 | -461.28 Million CNY | 30.33% |
| 2021 | -662.04 Million CNY | 21.87% |
| 2020 | -847.31 Million CNY | -0.35% |
| 2019 | -844.31 Million CNY | -591.45% |
| 2018 | -122.1 Million CNY | -60.7% |
| 2017 | -75.98 Million CNY | -1491.29% |
| 2016 | -4.77 Million CNY | -111.22% |
| 2015 | 42.54 Million CNY | 149.16% |
| 2014 | -86.55 Million CNY | -41.36% |
| 2013 | -61.23 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -179.46 Million CNY | 20.91% |
| 2024 Q2 | -187.1 Million CNY | -4.26% |
| 2024 Q3 | -88.41 Million CNY | 52.93% |
| 2023 Q3 | -224.49 Million CNY | 28.56% |
| 2023 Q1 | -342.53 Million CNY | 25.74% |
| 2023 Q4 | -226.91 Million CNY | -1.08% |
| 2023 FY | -226.91 Million CNY | 50.81% |
| 2023 Q2 | -314.25 Million CNY | 8.26% |
| 2022 Q3 | -384.67 Million CNY | 15.37% |
| 2022 FY | -461.28 Million CNY | 30.33% |
| 2022 Q1 | -536.17 Million CNY | 19.01% |
| 2022 Q4 | -461.28 Million CNY | -19.92% |
| 2022 Q2 | -454.54 Million CNY | 15.22% |
| 2021 FY | -662.04 Million CNY | 21.87% |
| 2021 Q4 | -662.04 Million CNY | -80.28% |
| 2021 Q3 | -367.23 Million CNY | 41.29% |
| 2021 Q2 | -625.56 Million CNY | -121.37% |
| 2021 Q1 | -282.58 Million CNY | 66.65% |
| 2020 Q3 | -328.63 Million CNY | 10.97% |
| 2020 Q4 | -847.31 Million CNY | -157.83% |
| 2020 Q1 | -899.21 Million CNY | -6.5% |
| 2020 FY | -847.31 Million CNY | -0.35% |
| 2020 Q2 | -369.1 Million CNY | 58.95% |
| 2019 Q2 | -124.06 Million CNY | -201.61% |
| 2019 Q3 | -142.4 Million CNY | -14.78% |
| 2019 Q1 | 122.1 Million CNY | 200.0% |
| 2019 FY | -844.31 Million CNY | -591.45% |
| 2019 Q4 | -844.31 Million CNY | -492.88% |
| 2018 FY | -122.1 Million CNY | -60.7% |
| 2018 Q4 | -122.1 Million CNY | 0.0% |
| 2017 FY | -75.98 Million CNY | -1491.29% |
| 2016 FY | -4.77 Million CNY | -111.22% |
| 2015 FY | 42.54 Million CNY | 149.16% |
| 2014 FY | -86.55 Million CNY | -41.36% |
| 2013 FY | -61.23 Million CNY | 0.0% |